317 related articles for article (PubMed ID: 9467687)
1. Depression in Parkinson's disease. Pharmacological characteristics and treatment.
Tom T; Cummings JL
Drugs Aging; 1998 Jan; 12(1):55-74. PubMed ID: 9467687
[TBL] [Abstract][Full Text] [Related]
2. Drug treatment strategies for depression in Parkinson disease.
Ryan M; Eatmon CV; Slevin JT
Expert Opin Pharmacother; 2019 Aug; 20(11):1351-1363. PubMed ID: 31120798
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson's Disease: An Updated Review.
Angelopoulou E; Stanitsa E; Karpodini CC; Bougea A; Kontaxopoulou D; Fragkiadaki S; Koros C; Georgakopoulou VE; Fotakopoulos G; Koutedakis Y; Piperi C; Papageorgiou SG
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629744
[TBL] [Abstract][Full Text] [Related]
4. Treatment options for depression and psychosis in Parkinson's disease.
Poewe W; Seppi K
J Neurol; 2001 Sep; 248 Suppl 3():III12-21. PubMed ID: 11697683
[TBL] [Abstract][Full Text] [Related]
5. Depression in patients with Parkinson's disease.
Cummings JL; Masterman DL
Int J Geriatr Psychiatry; 1999 Sep; 14(9):711-8. PubMed ID: 10479741
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis.
Mills KA; Greene MC; Dezube R; Goodson C; Karmarkar T; Pontone GM
Int J Geriatr Psychiatry; 2018 Apr; 33(4):642-651. PubMed ID: 29235150
[TBL] [Abstract][Full Text] [Related]
7. Severe depression: is there a best approach?
Sonawalla SB; Fava M
CNS Drugs; 2001; 15(10):765-76. PubMed ID: 11602003
[TBL] [Abstract][Full Text] [Related]
8. Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.
Heinonen EH; Myllylä V
Drug Saf; 1998 Jul; 19(1):11-22. PubMed ID: 9673855
[TBL] [Abstract][Full Text] [Related]
9. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
Smith KM; Eyal E; Weintraub D;
JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
[TBL] [Abstract][Full Text] [Related]
10. Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.
Burn DJ
Mov Disord; 2002 May; 17(3):445-54. PubMed ID: 12112190
[TBL] [Abstract][Full Text] [Related]
11. Drug Choices and Advancements for Managing Depression in Parkinson's Disease.
Assogna F; Pellicano C; Savini C; Macchiusi L; Pellicano GR; Alborghetti M; Caltagirone C; Spalletta G; Pontieri FE
Curr Neuropharmacol; 2020; 18(4):277-287. PubMed ID: 31622207
[TBL] [Abstract][Full Text] [Related]
12. Current approaches to management of depression in Parkinson's Disease.
Vajda FJ; Solinas C
J Clin Neurosci; 2005 Sep; 12(7):739-43. PubMed ID: 16026985
[TBL] [Abstract][Full Text] [Related]
13. Treatment of depression in Parkinson's disease.
Sawabini KA; Watts RL
Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S37-41. PubMed ID: 15109585
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
Hirschfeld RM
J Clin Psychiatry; 1999 May; 60(5):326-35. PubMed ID: 10362442
[TBL] [Abstract][Full Text] [Related]
15. Depression and Parkinson's disease.
Lemke MR; Fuchs G; Gemende I; Herting B; Oehlwein C; Reichmann H; Rieke J; Volkmann J
J Neurol; 2004 Sep; 251 Suppl 6():VI/24-7. PubMed ID: 15675721
[TBL] [Abstract][Full Text] [Related]
16. Moclobemide. An update of its pharmacological properties and therapeutic use.
Fulton B; Benfield P
Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
[TBL] [Abstract][Full Text] [Related]
17. Recent pharmacologic advances in antidepressant therapy for the elderly.
Preskorn SH
Am J Med; 1993 May; 94(5A):2S-12S. PubMed ID: 8503477
[TBL] [Abstract][Full Text] [Related]
18. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
Jankovic J; Stacy M
CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
[TBL] [Abstract][Full Text] [Related]
19. Depression in Parkinson's Disease: A Narrative Review.
Chikatimalla R; Dasaradhan T; Koneti J; Cherukuri SP; Kalluru R; Gadde S
Cureus; 2022 Aug; 14(8):e27750. PubMed ID: 36106206
[TBL] [Abstract][Full Text] [Related]
20. Recognition and treatment of depression in Parkinson's disease.
Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
J Geriatr Psychiatry Neurol; 2003 Sep; 16(3):178-83. PubMed ID: 12967062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
